End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 CAD | -2.76% |
|
-6.00% | +6.02% |
06-23 | Hamilton Thorne Maintained at Buy at Stifel GMP on No Impact From U.S. IVF Actions; Price Target Kept at C$2.55 | MT |
05-14 | Hamilton Thorne Q1 Loss Widens Even as Sales Increase | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.02% | 163M | |
+4.85% | 216B | |
+9.86% | 190B | |
+31.11% | 152B | |
+34.08% | 113B | |
+1.90% | 64.04B | |
+19.45% | 54.34B | |
+1.63% | 49.21B | |
-3.12% | 39.41B | |
+1.93% | 35.99B |
- Stock Market
- Equities
- HTL Stock
- News Hamilton Thorne Ltd.
- Hamilton Thorne Q3 Sales increased 16% YoY to US$15.7 Million